268 related articles for article (PubMed ID: 12373774)
21. Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis.
Bargagli E; Olivieri C; Nikiforakis N; Cintorino M; Magi B; Perari MG; Vagaggini C; Spina D; Prasse A; Rottoli P
Respir Physiol Neurobiol; 2009 Jul; 167(3):261-7. PubMed ID: 19464392
[TBL] [Abstract][Full Text] [Related]
22. Protein profiles of bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
Kriegova E; Melle C; Kolek V; Hutyrova B; Mrazek F; Bleul A; du Bois RM; von Eggeling F; Petrek M
Am J Respir Crit Care Med; 2006 May; 173(10):1145-54. PubMed ID: 16439718
[TBL] [Abstract][Full Text] [Related]
23. [Lipid peroxidation in bronchoalveolar lavage fluid in interstitial lung diseases in relation to other components and smoking].
Kawakami M; Kameyama S; Takizawa T
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):422-7. PubMed ID: 2796049
[TBL] [Abstract][Full Text] [Related]
24. [Fibrogenesis and glycoconjugates].
Motomiya M
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):418-21. PubMed ID: 2796048
[TBL] [Abstract][Full Text] [Related]
25. 2-DE and LC-MS/MS for a comparative proteomic analysis of BALf from subjects with different subsets of inflammatory myopathies.
Passadore I; Iadarola P; Di Poto C; Giuliano S; Montecucco C; Cavagna L; Bonino C; Meloni F; Fietta AM; Lisa A; Salvini R; Bardoni AM
J Proteome Res; 2009 May; 8(5):2331-40. PubMed ID: 19301896
[TBL] [Abstract][Full Text] [Related]
26. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis.
Koyama S; Sato E; Haniuda M; Numanami H; Nagai S; Izumi T
Am J Respir Crit Care Med; 2002 Aug; 166(3):382-5. PubMed ID: 12153975
[TBL] [Abstract][Full Text] [Related]
27. Chitotriosidase activity in patients with interstitial lung diseases.
Bargagli E; Margollicci M; Luddi A; Nikiforakis N; Perari MG; Grosso S; Perrone A; Rottoli P
Respir Med; 2007 Oct; 101(10):2176-81. PubMed ID: 17631992
[TBL] [Abstract][Full Text] [Related]
28. Induced sputum in patients with interstitial lung disease: a non-invasive surrogate for certain parameters in bronchoalveolar lavage fluid.
Sobiecka M; Kus J; Demkow U; Filewska M; Jozwik A; Radwan-Rohrenschef P; Chorostowska-Wynimko J
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():645-57. PubMed ID: 19218691
[TBL] [Abstract][Full Text] [Related]
29. Increased endothelin-1 levels of BAL fluid in patients with pulmonary sarcoidosis.
Terashita K; Kato S; Sata M; Inoue S; Nakamura H; Tomoike H
Respirology; 2006 Mar; 11(2):145-51. PubMed ID: 16548898
[TBL] [Abstract][Full Text] [Related]
30. Lavage type III procollagen N-terminal peptides in human pulmonary fibrosis and sarcoidosis.
Low RB; Cutroneo KR; Davis GS; Giancola MS
Lab Invest; 1983 Jun; 48(6):755-9. PubMed ID: 6855198
[TBL] [Abstract][Full Text] [Related]
31. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease.
Günther A; Mosavi P; Ruppert C; Heinemann S; Temmesfeld B; Velcovsky HG; Morr H; Grimminger F; Walmrath D; Seeger W
Thromb Haemost; 2000 Jun; 83(6):853-60. PubMed ID: 10896238
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of interleukin-13 in the serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis].
Xiao L; Li ZH; Hou XM; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Nov; 26(11):686-8. PubMed ID: 14703444
[TBL] [Abstract][Full Text] [Related]
33. [Change of matrix metalloproteinase-1 and matrix metalloproteinase-7 in serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and sarcoidosis].
Zhou LF; Jiang L; Li ZH; Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jun; 33(6):441-4. PubMed ID: 20979817
[TBL] [Abstract][Full Text] [Related]
34. Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis.
Rottoli P; Magi B; Perari MG; Liberatori S; Nikiforakis N; Bargagli E; Cianti R; Bini L; Pallini V
Proteomics; 2005 Apr; 5(5):1423-30. PubMed ID: 15761959
[TBL] [Abstract][Full Text] [Related]
35. [Measurement of small quantities of alpha 2-macroglobulin in bronchoalveolar lavage fluid by enzyme-labelled immunoassay, and its clinical implication in pulmonary disease].
Takasaki M; Bandou Y; Uchiyama Y; Ohtani H; Umehara M; Soma K; Ishikawa K; Katagiri M; Yanase N; Tomita T
Rinsho Byori; 1989 Jul; 37(7):825-9. PubMed ID: 2481759
[TBL] [Abstract][Full Text] [Related]
36. The clinical significance of interleukin 18 assessment in sarcoidosis patients.
Kieszko R; Krawczyk P; Jankowska O; Chocholska S; Król A; Milanowski J
Respir Med; 2007 Apr; 101(4):722-8. PubMed ID: 17015003
[TBL] [Abstract][Full Text] [Related]
37. [Level of NCF and TNF-alpha in the BALF of ILD patients and their clinical significance].
Chen W; Li Z; Hou X
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):297-9. PubMed ID: 11326956
[TBL] [Abstract][Full Text] [Related]
38. [Procollagen-III-peptide in bronchoalveolar lavage fluid as an index of fibrosis in sarcoidosis and idiopathic lung fibrosis?].
Teschler H; Costabel U; Ziesche R; Freitag L; Matthys H; Konietzko N
Pneumologie; 1990 Feb; 44 Suppl 1():217-8. PubMed ID: 2367369
[TBL] [Abstract][Full Text] [Related]
39. Protein patterns of human nasal and bronchoalveolar lavage fluids analyzed with two-dimensional gel electrophoresis.
Lindahl M; Ståhlbom B; Svartz J; Tagesson C
Electrophoresis; 1998 Dec; 19(18):3222-9. PubMed ID: 9932819
[TBL] [Abstract][Full Text] [Related]
40. Elevated alpha-defensin levels in plasma of patients with pulmonary sarcoidosis.
Ashitani J; Matsumoto N; Nakazato M
Respirology; 2007 May; 12(3):339-45. PubMed ID: 17539836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
